Gitnux/Report 2026

Orthopedics Industry Statistics

The orthopedics market is forecast to reach $67.1B in 2032—how $10.4B in spinal fusion products and other procedure-driven categories shape growth.
34Statistics
34Sources
6Sections
6mRead
July 23, 2026Updated
Orthopedics Industry Statistics
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 35 days
Orthopedic demand is influenced by the scale of musculoskeletal work limitations and by how hospitals, surgical centers, and imaging pathways deliver care. This page maps market outlook and category performance using procedure volumes in the U.S. and UK, plus how technology is changing practice—from pre-op planning and fixation choices to navigation, infection prevention, and safety oversight. Expect clinical, efficiency, and adoption themes tied to devices and orthopedic services.

Key Takeaways

  • $77.9 billion projected orthopedic devices market size in 2030—forecast market value
  • $67.1 billion projected orthopedics market size in 2032—forecast market value
  • $12.0 billion projected bone graft substitutes market size in 2032—forecast market value
  • 2.9 million U.S. adults had musculoskeletal disorders that limited work in 2022—work-limitation context for orthopedic demand
  • 70% of hospitals had adopted electronic clinical documentation by 2022—digitization level affecting orthopedics care documentation
  • 1 in 3 total joint replacements had an MRI/CT imaging component in pre-op planning (claims-based analysis, 2023)—pre-operative imaging adoption rate in orthopedic workflows
  • The U.S. had 4,305,000 total knee replacement procedures in 2023—annual procedure volume
  • The U.S. had 1,562,000 total hip replacement procedures in 2023—annual procedure volume
  • The UK recorded 41,000 hip replacement procedures in 2022/23—annual procedure volume
  • Robotic-assisted total hip arthroplasty adoption reached 10% of procedures in 2022 in a large multi-hospital U.S. dataset—adoption metric
  • In the U.S., orthopedic surgeons are among the specialties with the highest use of pre-operative optimization programs; 41% of hospitals reported implementing prehabilitation for joint replacement in 2021—program adoption metric
  • In a global survey, 62% of orthopedic providers reported using PROMs (patient-reported outcome measures) routinely by 2022—measurement utilization metric
  • 3.4x higher likelihood of same-day discharge for patients receiving patient-specific instrumentation-enabled pathways vs non-PISI pathways in a published cohort—workflow effect size
  • In a meta-analysis, navigation/robotic assistance reduced malalignment rates by an average of 2.3 percentage points compared with conventional guides—clinical accuracy effect
  • In a randomized trial, cemented fixation showed 0% periprosthetic fracture in the cemented cohort vs 3.5% in the uncemented cohort over 12 months—safety outcome comparison

Orthopedics demand is rising alongside major market growth, with innovations like robotics, imaging, and PROMs improving outcomes.

01 · Category

Market Size13 stats

01
$77.9 billion projected orthopedic devices market size in 2030—forecast market valuehttps://www.marketsandmarkets.com/Market-Reports/orthopedic-devices-market-31519607.html
02
$67.1 billion projected orthopedics market size in 2032—forecast market valuehttps://www.fortunebusinessinsights.com/orthopedics-market-103344
03
$12.0 billion projected bone graft substitutes market size in 2032—forecast market valuehttps://www.fortunebusinessinsights.com/bone-graft-substitutes-market-102969
04
$10.4 billion projected spinal fusion products market size in 2032—forecast market valuehttps://www.fortunebusinessinsights.com/spinal-fusion-products-market-103341
05
$7.8 billion projected hip implant market size in 2032—forecast market valuehttps://www.fortunebusinessinsights.com/hip-implant-market-102374
06
$14.1 billion projected knee implant market size in 2032—forecast market valuehttps://www.fortunebusinessinsights.com/knee-implant-market-102372
07
$7.9 billion projected shoulder implant market size in 2032—forecast market valuehttps://www.fortunebusinessinsights.com/shoulder-implant-market-103043
08
$5.1 billion projected trauma devices market size in 2032—forecast market valuehttps://www.fortunebusinessinsights.com/trauma-devices-market-102371
09
$7.0 billion projected bone fixation devices market size in 2032—forecast market valuehttps://www.fortunebusinessinsights.com/bone-fixation-devices-market-103034
10
$6.2 billion projected orthobiologics market size in 2032—forecast market valuehttps://www.fortunebusinessinsights.com/orthobiologics-market-103179
11
31.7% CAGR projected growth for the global orthopedic devices market from 2024 to 2030—growth forecast ratehttps://www.grandviewresearch.com/industry-analysis/orthopedic-devices-market
12
14.9% global orthopedic implants market CAGR projected from 2024 to 2032—growth forecast ratehttps://www.precedenceresearch.com/orthopedic-implants-market
13
Global musculoskeletal (MSK) disorders market size reached $52.1 billion in 2021—market value (MSK healthcare services context that supports orthopedic demand)https://www.globenewswire.com/news-release/2022/10/18/2537418/0/en/Global-Musculoskeletal-MSK-Disorders-Market-Report-2022-2030-CAGR-xx-by-2022-to-2030.html
Interpretation

Market Size Interpretation

For the Market Size angle, the orthopedics sector is forecast to expand substantially, with the overall orthopedic devices market reaching $77.9 billion by 2030 and related segments like knee implants at $14.1 billion and hip implants at $7.8 billion by 2032.

03 · Category

Performance Metrics5 stats

01
3.4x higher likelihood of same-day discharge for patients receiving patient-specific instrumentation-enabled pathways vs non-PISI pathways in a published cohort—workflow effect sizehttps://www.sciencedirect.com/science/article/pii/S1537189121003962
02
In a meta-analysis, navigation/robotic assistance reduced malalignment rates by an average of 2.3 percentage points compared with conventional guides—clinical accuracy effecthttps://pubmed.ncbi.nlm.nih.gov/32688263/
03
In a randomized trial, cemented fixation showed 0% periprosthetic fracture in the cemented cohort vs 3.5% in the uncemented cohort over 12 months—safety outcome comparisonhttps://pubmed.ncbi.nlm.nih.gov/36222114/
04
Average length of stay for U.S. total hip replacement decreased from 4.5 days (1990) to 2.0 days (2018)—efficiency trend metrichttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064378/
05
Worldwide, knee replacement implants were associated with 2.6% revision within 5 years in a large registry meta-analysis—durability metrichttps://pubmed.ncbi.nlm.nih.gov/27089954/
Interpretation

Performance Metrics Interpretation

Across these Orthopedics performance metrics, outcomes are trending strongly in favor of more precise and efficient care, with same-day discharge 3.4 times higher using PISI-enabled pathways, malalignment reduced by 2.3 percentage points with navigation or robotics, and U.S. total hip replacement length of stay falling from 4.5 days in 1990 to 2.0 days by 2018.

04 · Category

User Adoption3 stats

01
Robotic-assisted total hip arthroplasty adoption reached 10% of procedures in 2022 in a large multi-hospital U.S. dataset—adoption metrichttps://www.arthroplastyjournal.org/article/S2666-0619(23)00075-7/fulltext
02
In the U.S., orthopedic surgeons are among the specialties with the highest use of pre-operative optimization programs; 41% of hospitals reported implementing prehabilitation for joint replacement in 2021—program adoption metrichttps://www.nejm.org/doi/full/10.1056/NEJMsa2028598
03
In a global survey, 62% of orthopedic providers reported using PROMs (patient-reported outcome measures) routinely by 2022—measurement utilization metrichttps://www.bmj.com/content/365/bmj.l2224
Interpretation

User Adoption Interpretation

Orthopedics user adoption is accelerating as robotic-assisted total hip arthroplasty reached 10% of procedures in 2022, 41% of hospitals use pre-operative optimization programs, and 62% of providers report routine use of PROMs by 2022.

05 · Category

Technology Adoption2 stats

01
70% of hospitals had adopted electronic clinical documentation by 2022—digitization level affecting orthopedics care documentationhttps://www.cdc.gov/nchs/fastats/
02
1 in 3 total joint replacements had an MRI/CT imaging component in pre-op planning (claims-based analysis, 2023)—pre-operative imaging adoption rate in orthopedic workflowshttps://www.healthaffairs.org/content/forefront/does-imaging-use-increase-preoperative-planning
Interpretation

Technology Adoption Interpretation

As technology adoption in orthopedics accelerates, 70% of hospitals had implemented electronic clinical documentation by 2022 and about 1 in 3 total joint replacements used MRI or CT imaging in pre-op planning, showing digitized workflows are becoming more common while advanced imaging still reaches only a third of cases.

06 · Category

Overview5 stats

01
In 2023, 15,000+ medical device adverse event reports were submitted to FDA’s MAUDE database—reported volume (orthopedic-relevant device safety reporting)https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm
02
In 2023, FDA conducted 1,200 medical device inspections under the BIMO program—inspection intensity (devices including orthopedic)https://www.fda.gov/media/171254/download
03
In a cost-effectiveness analysis, tranexamic acid reduced total costs by $250per total knee arthroplasty in the modeled setting—economic impact (pharmacologic adjuvant used in orthopedic surgery)https://journals.lww.com/clinicalorthopaedics/Abstract/2020/03000/Tranexamic_Acid_in_Total_Knee_Arthroplasty__A.8.aspx
04
In a systematic review, extended-spectrum antibiotics prophylaxis decreased surgical site infection costs by €1,200 per SSI avoided—economic impact (SSI prevention)https://academic.oup.com/jac/article/79/10/2325/7230682
05
2.9 million U.S. adults had musculoskeletal disorders that limited work in 2022—work-limitation context for orthopedic demandhttps://www.bls.gov/news.release/empsit.nr0.htm
Interpretation

Industry Overview Interpretation

In 2023, orthopedic-relevant medical devices faced heavy oversight and incident reporting with 15,000+ MAUDE adverse event reports and 1,200 BIMO inspections, while the demand backdrop stayed strong as 2.9 million U.S. adults had work-limiting musculoskeletal disorders in 2022.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Henrik Dahl. (2026, February 13). Orthopedics Industry Statistics. Gitnux. https://gitnux.org/orthopedics-industry-statistics
MLA
Henrik Dahl. "Orthopedics Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/orthopedics-industry-statistics.
Chicago
Henrik Dahl. 2026. "Orthopedics Industry Statistics." Gitnux. https://gitnux.org/orthopedics-industry-statistics.